I think Matt's analysis is the first clean, understandable interpretation I have seen. It explains clearly that BTX1503 failed the Phase 2 and its back to the drawing board.
thanks Matt for the concise analysis.
- Forums
- ASX - By Stock
- BOT 1503 Study Analysis
I think Matt's analysis is the first clean, understandable...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.5¢ | 38.0¢ | 35.0¢ | $3.984M | 10.86M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 299394 | 37.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 421264 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 243100 | 0.370 |
17 | 285484 | 0.365 |
11 | 387994 | 0.360 |
10 | 683992 | 0.355 |
11 | 736727 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 171423 | 5 |
0.380 | 452861 | 18 |
0.385 | 307424 | 9 |
0.390 | 723886 | 12 |
0.395 | 352644 | 12 |
Last trade - 15.53pm 15/07/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online